title: Regulatory evaluation of Glybera in Europe - two committees, one mission.
authors: Department of Physiology and Pharmacology, the University of Rome "Sapienza", P.le Aldo Moro 5, 00185 Rome, Italy; member of the Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA), 7 Westferry Circus, Canary Wharf, London E14 4HB, UK.
authors: Daniela
authors: D
authors: Melchiorri
authors: Luca
authors: L
authors: Pani
authors: Paolo
authors: P
authors: Gasparini
authors: Giulio
authors: G
authors: Cossu
authors: Janis
authors: J
authors: Ancans
authors: John Joseph
authors: JJ
authors: Borg
authors: Catherine
authors: C
authors: Drai
authors: Piotr
authors: P
authors: Fiedor
authors: Egbert
authors: E
authors: Flory
authors: Ian
authors: I
authors: Hudson
authors: Hubert G
authors: HG
authors: Leufkens
authors: Jan
authors: J
authors: Müller-Berghaus
authors: Gopalan
authors: G
authors: Narayanan
authors: Brigitte
authors: B
authors: Neugebauer
authors: Juris
authors: J
authors: Pokrotnieks
authors: Jean-Louis
authors: JL
authors: Robert
authors: Tomas
authors: T
authors: Salmonson
authors: Christian K
authors: CK
authors: Schneider
mesh_terms: D003299:Cooperative Behavior; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D005062:European Union; D015316:Genetic Therapy / Q000331:legislation & jurisprudence*; D006801:Humans; D008072:Hyperlipoproteinemia Type I / Q000235:genetics / Q000628:therapy*
references: Nat Rev Drug Discov. 2012 Sep;11(9):664
references: 22935793
references: Nat Rev Drug Discov. 2012 May;11(5):419
references: 22679644
references: Mol Ther. 2012 Mar;20(3):479-82
references: 22378030
references: Mol Ther. 2012 Mar;20(3):471-2
references: 22378026
references: Nat Biotechnol. 2012 Jun 07;30(6):474
references: 22678366